RGCB Gets ₹7 Crore to Develop a Blood-Based Cervical Cancer Test
Rajiv Gandhi Centre for Biotechnology has secured a ₹7 crore grant to develop a blood-based cervical cancer detection device. What gynaecology clinics should know.
Private Capital Keeps Flowing Into Hospital Chains
Nearly $10 billion of private equity has gone into Indian hospital chains in five years. What chain expansion means for independent specialists.
Tata Trusts Plans 40–50 Not-for-Profit Hospitals
Tata Trusts is working towards a network of 40 to 50 not-for-profit general hospitals, using a cross-subsidy model. What it could mean for private clinics.
NMC Sets Appeal Route for Doctors Penalised Under Advertising Guidelines
NMC names its Ethics and Medical Registration Board as the appellate authority for doctors penalised under the new ethical advertising guidelines.
Paras Healthcare IPO: What a Hospital Chain Listing Signals
Paras Healthcare raised ₹652.5 crore from anchor investors ahead of its ₹1,450 crore IPO. Why hospital-chain fundraising matters for independent clinics.
NMC Clarifies Doctors Can Digitally Sign Medical Reports Remotely
An NMC clarification on remote authentication of electronic medical records, and what clinics and diagnostic set-ups should put in place.
NMC Ad Rules Cover Nursing Homes and Clinics, Not Just Doctors
The NMC’s October 2026 advertising guidelines define hospitals using the Clinical Establishments Act, covering nursing homes and clinics too. What that means for your clinic.
e-Sushrut@Clinic: Low-Cost Cloud HMS for Small Clinics
A background note on e-Sushrut@Clinic, the C-DAC cloud hospital management system for small clinics, with pricing as reported and one check for clinic owners.
CDSCO Flags 330 Substandard Drug Samples in September
CDSCO’s September 2026 alert lists 330 Not of Standard Quality drug samples and one spurious sample. What it means for clinics with in-house pharmacies.
Draft Rules Would Extend Prescription Drug Ad Limits to Pharmacies
A draft Health Ministry proposal would extend prior-approval limits on Schedule H, H1 and X drug advertising to sellers. What clinics with pharmacies should check.
